Journal Of The American Academy Of Dermatology[JOURNAL]

Nikolaou V, Koumprentziotis IA, Gerochristou M … +9 more , Patsatsi A, Tsimpidakis A, Tsitlakidou A, Soura E, Kemanetzi C, Routsi E, Lazaridou E, Stratigos A, Apalla Z

J Am Acad Dermatol · 2026 Jun · PMID 42264373 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

On call or on demand: Ethical implications of sharing personal phone numbers with patients.

Nguyen NAH, Nasari AS, Klufas T … +2 more , Zhou AE, Grant-Kels JM

J Am Acad Dermatol · 2026 Jun · PMID 42264372 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Evolving medicolegal liability patterns in GLP-1 receptor agonist prescribing.

Barnawi G, Amara C, Lipner SR

J Am Acad Dermatol · 2026 Jun · PMID 42264371 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Assessment of the Efficacy and Safety of 50% Glycolic Acid, 30% Salicylic Acid, and Modified Jessner's Chemical Peels in the Treatment of Active Acne and Post-acne Hyperpigmentation: Randomized Controlled Trial.

Hamza Dorgham DA, Muthanna LA, Mahran NM

J Am Acad Dermatol · 2026 Jun · PMID 42264092 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

State-by-state variability in presumptive workers' compensation coverage for firefighter skin cancer: Implications for dermatologic documentation and access to care.

Gandhi I, Zhang R, Fayyad D … +6 more , Shetty R, Barnawi G, Fishman C, Chaudhry N, Meisenheimer J, Dellavalle RP

J Am Acad Dermatol · 2026 Jun · PMID 42262293 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Efficacy of upadacitinib for the treatment alopecia areata: A systematic review and meta-analysis.

Barnawi G, Lazarowitz R, Nukaly HY … +7 more , Creighton R, Ridha Z, Aldein AS, Algaidi Y, Weiss E, Litvinov IV, Donovan J

J Am Acad Dermatol · 2026 Jun · PMID 42251939 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Retrospective study on the association between bariatric surgery and disease activity of pediatric hidradenitis suppurativa.

Nasseri M, Tucker A, Sherman C … +4 more , Nadler E, Koutroulis I, Stein AB, Cotton C

J Am Acad Dermatol · 2026 Jun · PMID 42250729 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Early biologic therapy and reduced acute healthcare utilization in hidradenitis suppurativa: A real-world analysis using TriNetX.

Kadam P, Lipner SR

J Am Acad Dermatol · 2026 Jun · PMID 42250728 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Optimizing Military Teledermatology: A Controlled Interventional Study on the Impact of a Standardized Store-and-Forward Protocol.

Laghi A, Astorino S, Nunno DDI … +7 more , Chello C, Fraia MDI, Michelini S, Occhicone F, Mucciante L, Troiani G, Pellacani G

J Am Acad Dermatol · 2026 Jun · PMID 42250727 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Pregnancy outcomes in patients with biologic-exposed psoriasis: A large cohort study of real-world safety.

Bar D, Pavlotsky F, Barzilai A … +2 more , Yinon Y, Baum M

J Am Acad Dermatol · 2026 Jun · PMID 42250726 · Publisher ↗

BACKGROUND: Pregnancy safety data for biologic therapies in psoriasis remain limited. OBJECTIVE: To compare overall and individual adverse pregnancy outcomes (APOs) between reproductive-age women with psoriasis exposed t... BACKGROUND: Pregnancy safety data for biologic therapies in psoriasis remain limited. OBJECTIVE: To compare overall and individual adverse pregnancy outcomes (APOs) between reproductive-age women with psoriasis exposed to biologic agents and unexposed psoriasis controls. METHODS: We performed a cohort study including females aged 15 to 49 years exposed to biologics during pregnancy. APOs were compared between biologic-exposed pregnancies and unexposed psoriasis controls. RESULTS: A total of 1226 biologic-exposed psoriasis patients and 1238 unexposed psoriasis controls were included. Any APO occurred in 24.1% of biologic-exposed patients versus 30.0% of unexposed controls (OR 0.76; 95% CI, 0.64-0.89; P = .0013). Biologics were associated with lower odds of spontaneous abortion (8.40% vs 10.90%; OR 0.75; 95% CI, 0.57-0.98; P = .0406), gestational diabetes mellitus (4.16% vs 7.43%; OR 0.54; 95% CI, 0.38-0.77; P = .00,054), and any APO overall. LIMITATIONS: Retrospective design, limited power for non-TNF-α biologic subclasses, and incomplete characterization of trimester-specific exposure duration. CONCLUSIONS: Biologic-exposed psoriasis patients did not exhibit increased risk of any adverse pregnancy outcome compared with unexposed controls.

Get PDF PubMed ↗

Incidence, clinical characteristics and risk factors for infantile hemangioma ulceration after oral propranolol initiation: A retrospective study.

Zhang K, Qiu T, Gong X … +6 more , Zhou J, Yang L, Han Y, Lan Y, Zhang Y, Ji Y

J Am Acad Dermatol · 2026 Jun · PMID 42250725 · Publisher ↗

BACKGROUND: Some patients with infantile hemangioma (IH) still develop ulcerations during oral propranolol, but these IH ulcerations have not been systematically studied. OBJECTIVE: To analyze the incidence, clinical fea... BACKGROUND: Some patients with infantile hemangioma (IH) still develop ulcerations during oral propranolol, but these IH ulcerations have not been systematically studied. OBJECTIVE: To analyze the incidence, clinical features and risk factors associated with IH ulceration after oral propranolol initiation. METHODS: Retrospective study at one tertiary referral center. RESULTS: We evaluated 470 patients with IH who received oral propranolol and 51 patients with nonintervention IH ulceration; 24 (5.1%) developed IH ulceration during oral propranolol. The median age at the discovery of IH ulceration was 3.9 months in the IH ulceration group after oral propranolol initiation, which was significantly later than the 2.0 months in the nonintervention IH ulceration group (P = .013). Multivariate analysis revealed that mixed IH (odds ratio [OR] = 5.620; 95% confidence interval [CI]: 1.419-22.265), indeterminate IH (OR = 8.219; 95% CI: 1.560-43.305), and segmental IH (OR = 22.806; 95% CI: 2.157-241.028) were independent risk factors for IH ulceration after oral propranolol initiation. Conversely, IH on the trunk (OR = 0.063, 95% CI: 0.007-0.580) and extremity (OR = 0.016, 95% CI: 0.001-0.289) were protective factors. LIMITATIONS: This was a single-center retrospective study. CONCLUSIONS: This study reports the incidence of IH ulceration in patients who received oral propranolol and identifies risk factors associated with IH ulceration after oral propranolol initiation.

Get PDF PubMed ↗

Lower artificial intelligence and clinician-derived dermoscopy scores in melanomas from CDKN2A pathogenic variant carriers compared to sporadic cases.

Rauwerdink D, Sangers T, van Not O … +1 more , van Doorn R

J Am Acad Dermatol · 2026 Jun · PMID 42250724 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

A randomized controlled trial to assess the effect of adding hypnoanesthesia to existing standard infiltration anesthetic technique as compared to standard infiltration anesthetic technique alone in pediatric population undergoing minor dermatosurgical procedures.

Yadav P, Gowda SK, Dudani P … +4 more , Verma KK, Mani K, Sahni K, Gupta S

J Am Acad Dermatol · 2026 Jun · PMID 42249868 · Publisher ↗

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Journal Of The American Academy Of Dermatology[JOURNAL]

About